<div id="readability-page-1"><p>Addus HomeCare Corporation (NASDAQ:ADUS - Get Free Report) EVP Roberton James Stevenson sold 567 shares of Addus HomeCare stock in a transaction on Tuesday, February 24th. The shares were sold at an average price of $107.35, for a total value of $60,867.45. Following the completion of the sale, the executive vice president directly owned 14,314 shares of the company's stock, valued at $1,536,607.90. This trade represents a 3.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.</p><p>Roberton James Stevenson also recently made the following trade(s): </p><ul><li>On Wednesday, February 25th, Roberton James Stevenson sold 284 shares of Addus HomeCare stock. The shares were sold at an average price of $105.36, for a total value of $29,922.24. </li></ul><div><p><span></span><span>Get <strong>Addus HomeCare</strong> alerts:</span></p></div><h2>Addus HomeCare Trading Down 3.3%</h2><p>NASDAQ:ADUS traded down $3.58 on Thursday, hitting $104.02. 269,378 shares of the stock were exchanged, compared to its average volume of 239,147. The stock has a market capitalization of $1.92 billion, a price-to-earnings ratio of 19.97, a P/E/G ratio of 1.26 and a beta of 0.91. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.66 and a current ratio of 1.80. Addus HomeCare Corporation has a 52 week low of $88.96 and a 52 week high of $124.43. The company's 50-day moving average price is $109.57 and its 200 day moving average price is $113.08. </p><h2>Institutional Inflows and Outflows</h2><p>Several institutional investors and hedge funds have recently modified their holdings of ADUS. TimesSquare Capital Management LLC grew its position in shares of  Addus HomeCare by 6.2% in the 3rd quarter. TimesSquare Capital Management LLC now owns 418,348 shares of the company's stock valued at $49,361,000 after acquiring an additional 24,301 shares during the period.  Russell Investments Group Ltd. lifted its stake in  Addus HomeCare by 10.1% in the 2nd quarter. Russell Investments Group Ltd. now owns 55,900 shares of the company's stock valued at $6,439,000 after purchasing an additional 5,110 shares during the last quarter.  Public Sector Pension Investment Board grew its holdings in  Addus HomeCare by 14.4% during the third quarter. Public Sector Pension Investment Board now owns 70,827 shares of the company's stock worth $8,357,000 after purchasing an additional 8,893 shares during the period.  Creative Planning increased its position in  Addus HomeCare by 150.9% during the second quarter. Creative Planning now owns 7,024 shares of the company's stock worth $809,000 after buying an additional 4,224 shares during the last quarter.  Finally, Tributary Capital Management LLC raised its stake in  Addus HomeCare by 114.1% in the third quarter. Tributary Capital Management LLC now owns 398,122 shares of the company's stock valued at $46,974,000 after buying an additional 212,192 shares during the period. 95.35% of the stock is owned by institutional investors and hedge funds. </p><h2>Analyst Upgrades and Downgrades</h2><p>A number of research firms have recently weighed in on ADUS. Stephens cut their price target on Addus HomeCare from $140.00 to $135.00 and set an &#34;overweight&#34; rating on the stock in a research note on Wednesday. KeyCorp  restated an &#34;overweight&#34; rating on shares of Addus HomeCare in a research report on Wednesday. Truist Financial  set a $135.00 price objective on shares of Addus HomeCare and gave the stock a &#34;buy&#34; rating in a research note on Wednesday, January 7th. Royal Bank Of Canada  restated an &#34;outperform&#34; rating and set a $139.00 price objective on shares of Addus HomeCare in a report on Wednesday. Finally, Barclays cut their target price on shares of Addus HomeCare from $117.00 to $112.00 and set an &#34;underweight&#34; rating on the stock in a report on Tuesday. One analyst  has rated the stock with a Strong Buy rating, seven have assigned  a Buy rating, two have issued  a Hold rating and one  has given a Sell rating to the company's stock. According to MarketBeat, Addus HomeCare presently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $134.33.</p><p><b>Read Our Latest Stock Report on ADUS</b></p><h2>More Addus HomeCare News</h2><p>Here are the key news stories impacting Addus HomeCare this week:</p><ul>   <li><span>Positive Sentiment: </span>Q4 earnings/earnings call emphasized continued revenue growth, margin-leverage opportunities and an M&amp;A-driven growth strategy for 2026 — supports longer‑term earnings upside. <i></i><span>Addus HomeCare Earnings Call Highlights Growth And Scale</span></li>    <li><span>Positive Sentiment: </span>Stephens trimmed its price target from $140 to $135 but kept an &#34;overweight&#34; rating — the new target implies meaningful upside from current levels, indicating analyst confidence in the company’s outlook despite the cut. <i></i><span>Stephens price target note</span></li>    <li><span>Neutral Sentiment: </span>Addus will participate in the Raymond James Institutional Investors Conference (investor visibility event; typically neutral but can aid liquidity/coverage). <i></i><span>Conference participation</span></li>    <li><span>Neutral Sentiment: </span>Some published short‑interest data in the feed shows zero shares (data glitch/inconsistent reporting across sources) — treat those specific zero figures with caution. <i></i><span>MarketBeat ADUS page</span></li>    <li><span>Negative Sentiment: </span>Significant insider selling over Feb. 24–25: CEO R. Dirk Allison sold two blocks (4,988 and 2,364 shares) and multiple senior EVPs sold smaller blocks across the two days — coordinated insider sales can pressure sentiment even if individual sales are routine and pre‑planned. See CEO filing. <i></i><span>CEO insider-sale SEC filing</span></li>    <li><span>Negative Sentiment: </span>Short interest rose earlier in February (as of Feb. 13 there were ~1.15M shares short, ~6.5% of shares outstanding and ~4.6 days‑to‑cover) — elevated short activity can amplify downward price moves. <i></i><span>Short interest data</span></li> </ul><h2>About Addus HomeCare</h2> (Get Free Report)<p>Addus HomeCare <span>NASDAQ: ADUS<span></span></span> is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients' independence and quality of life.  </p><p>The company's core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.</p><h2>Read More</h2><ul><li>Five stocks we like better than Addus HomeCare</li><li>Unlocked: Elon Musk’s Next Big IPO</li><li>REVEALED: Something Big Happening Behind White House Doors</li><li>This makes me furious</li><li>The free stock picks nobody’s talking about</li><li>Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QURVUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QURVUw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Addus HomeCare Right Now?</h2><p>Before you consider Addus HomeCare, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.</p><p>While Addus HomeCare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

ADUS

<p>Addus HomeCare EVP Roberton James Stevenson sold 567 shares at $107.35 each, totaling $60,867.45, reducing his ownership by 3.81%. He now holds 14,314 shares valued at approximately $1.54 million. The stock recently traded down 3.3% to $104.02. Institutional investors hold 95.35% of the stock, with several firms adjusting their positions. Analysts have mixed ratings on ADUS, with a consensus target price of $134.33 and a general rating of "Moderate Buy."</p>

Addus HomeCare (NASDAQ:ADUS) EVP Roberton James Stevenson Sells 567 Shares